Search results
Eli Lilly Alzheimer's drug approved by US FDA
Hindustan Times· 2 days agoThe U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing...
USFDA approves Eli Lilly’s drug to treat Alzheimer’s in adults
Financial Express· 1 day agoThe United States Food and Drug Administration (USFDA) on Tuesday approved a new Alzheimer’s drug...
India Approves The Weight Loss & Diabetes Drugs: Everything You Need To Know About It
NDTV· 21 hours agoEli Lilly and Co., the pharmaceutical company, has secured the first approvals for the import and...
Eli Tomac Aims for AMA Pro Motocross Comeback at Budds Creek
Motocross· 2 days agoA crash at the Denver Monster Energy AMA Supercross resulted in a Bennetts fracture and some torn...
Waiting for a wonder drug? The weight just got longer
The Economic Times· 10 hours agoEli Lilly has yet to get the nod from India's drug regulator for selling its blockbuster drug...
Eli Lilly Alzheimer's drug approved by US FDA - ET HealthWorld | Pharma
The Economic Times· 23 hours agoLondon: The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early...
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Pharmaceutical Technology· 19 hours agoAs Eli Lilly’s Kisunla (donanemab) enters the Alzheimer's treatment space, its leading competitor...
US Regulator Approves Eli Lilly Drug For Early Alzheimer Treatment - News18
News18· 1 day agoThe US Food and Drug Administration (FDA) approved a drug made by Eli Lilly on Tuesday that is...
Blockbuster diabetes & obesity drug gets nod for India launch but may be available only next year
Theprint· 2 days ago“The company now has the regulatory approval in place to launch the drug in India but we can do that in about six months from now after assessing the drug’s global supply chain status,” a source ...
Eli Lilly continues radiopharma push with $140m Radionetics partnership
Pharmaceutical Technology· 2 days agoEli Lilly has partnered with Radionetics Oncology in a $140m deal, as the drugmaker aims to get a...